Keyword: cancer drug


Large-Scale Production Announced by Epsilogen and Lonza for Ovarian Cancer Treatment

05.03.2024 -

Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out...


US Merck Halts Trial Enrollment After Deaths

14.06.2017 - US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...


Bicycle Gains Funds for Cancer Drug Trials

01.06.2017 - UK biotech Bicycle Therapeutics has raised £40 million from a Series B financing round to advance the development of multiple candidate drugs to treat cancers with a high unmet...


Crescendo Biologics and Takeda in Cancer Drug Pact

12.10.2016 - The UK’s Crescendo Biologics is collaborating with Japanese drugmaker Takeda Pharmaceutical Company in a deal worth $790 million. The partners have announced a global, strategic...


Genentech Buys Rights to Hanmi’s Cancer Drug

06.10.2016 - US biotechnology group Genentech has agreed with Hanmi Pharmaceutical to buy the exclusive global rights to the South Korean company’s experimental cancer drug HM95573. The...


Ipsen Pays $855 Million for Exelixis’ Cancer Drug

07.03.2016 - French pharmaceutical company Ipsen is paying up to $855 million for the rights to Exelixis’ cancer drug Cabozantinib. Under the deal, Exelixis gains exclusive commercialization...